ACCELOPMENT SCHWEIZ AG

Their core work

Accelopment is a Swiss SME specializing in EU project management, dissemination, communication, and exploitation support. They do not conduct primary research themselves — instead, they provide professional services to research consortia across a wide range of scientific domains. Their participation in 24 H2020 projects spanning topics from quantum sensors to veterinary epidemiology confirms a domain-agnostic service role. They are particularly active in MSCA training networks, where they likely handle coordination of training, outreach, and knowledge transfer activities.

What they specialise in

How they've shifted over time

In the early period (2015–2018), Accelopment focused heavily on MSCA training networks and materials-oriented research projects (exoskeletons, perovskite solar cells, advanced textiles, immersive visual technologies). From 2019 onward, their portfolio shifted toward health and life sciences (diabetes, COVID-19, dementia screening, immunomics) and data-driven projects involving AI and machine learning. Their average funding per project also increased in the later period, with AI-Mind (EUR 851K) and DECIDE (EUR 512K) being their largest grants — suggesting they are taking on larger service roles in bigger consortia.

Moving toward larger health and AI consortia with growing project budgets, indicating increased trust from consortium coordinators and expanding service capacity.

How they like to work

Accelopment never leads projects — zero coordinator roles across 24 projects. They join as either a participant (15 projects) or third-party partner (9 projects), always in a supporting capacity. With 305 unique consortium partners across 30 countries, they operate as a high-connectivity hub rather than a loyal repeat-partner organization. This makes them an excellent choice when a consortium needs a reliable, experienced project management partner who already knows how EU projects work.

Exceptionally broad network of 305 unique partners across 30 countries, built through participation in 24 diverse projects. Their reach spans nearly all of Europe with no strong geographic bias, reflecting their role as a versatile service provider welcomed into consortia regardless of domain.

What sets them apart

Accelopment's value lies in being a domain-agnostic EU project services firm with deep experience across multiple H2020 pillars — from MSCA training networks to RIA and IA projects. Unlike technical partners who bring subject-matter expertise, they bring process expertise: managing dissemination, communication, exploitation, and training activities so that researchers can focus on research. Their Swiss base and 305-partner network make them a trusted, well-connected addition to any consortium needing professional project support.

Highlights from their portfolio

• AI-Mind
  Their largest single grant (EUR 851,250) in a high-profile AI and dementia screening project running until 2026, signaling growing trust and responsibility.
• DECIDE
  Second-largest grant (EUR 512,500) in veterinary epidemiology and decision support — demonstrates their ability to support complex data-driven projects in food and agriculture.
• macQsimal
  Quantum sensing project (miniature atomic vapor cells) — an unusual deep-tech domain showing their versatility in supporting frontier physics research.